Neidio i'r cynnwys
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Iaith
Pob Maes
Teitl
Awdur
Pwnc
Rhif Galw
ISBN/ISSN
Tag
Canfod
Uwch
A SYSTEMATIC REVIEW AND META-A...
Dyfynnu hwn
Anfonwch hwn fel neges destun
E-bostio hwn
Argraffu
Allforio Cofnod
Allforio i RefWorks
Allforio i EndNoteWeb
Allforio i EndNote
Permanent link
A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (RCTS) OF EGFR-TARGETED MONOCLONAL ANTIBODY (MAB) THERAPY IN ADVANCED COLORECTAL CANCER (ACRC): IMPACT OF K-RAS STATUS
Manylion Llyfryddiaeth
Prif Awduron:
Vale, C
,
Tierney, J
,
Meade, A
,
Fisher, D
,
Kaplan, R
,
Adams, R
,
Maughan, T
,
Parmar, M
Fformat:
Journal article
Cyhoeddwyd:
2009
Daliadau
Disgrifiad
Eitemau Tebyg
Dangos Staff
Eitemau Tebyg
Impact of K-ras status on the effects of EGFR-targeted monoclonal antibody (MAb) therapy in advanced colorectal cancer (ACRC): A systematic review and meta-analysis of randomized controlled trials (RCTs)
gan: Vale, C, et al.
Cyhoeddwyd: (2009)
Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis.
gan: Vale, C, et al.
Cyhoeddwyd: (2012)
Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis
gan: Vale, C, et al.
Cyhoeddwyd: (2012)
THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED
gan: Maughan, T, et al.
Cyhoeddwyd: (2010)
Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)
gan: Maughan, T, et al.
Cyhoeddwyd: (2009)